Maryland State Retirement & Pension System’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Hold
9,571
0.01% 891
2026
Q1
$541K Hold
9,571
0.01% 788
2025
Q4
$569K Hold
9,571
0.01% 756
2025
Q3
$518K Buy
9,571
+746
+8% +$42.7K 0.01% 789
2025
Q2
$485K Hold
8,825
0.01% 968
2025
Q1
$624K Sell
8,825
-1,256
-12% -$84.5K 0.01% 792
2024
Q4
$663K Sell
10,081
-706
-7% -$47.3K 0.01% 884
2024
Q3
$758K Sell
10,787
-3,523
-25% -$294K 0.02% 821
2024
Q2
$1.18M Hold
14,310
0.02% 595
2024
Q1
$1.29M Hold
14,310
0.03% 539
2023
Q4
$1.38M Hold
14,310
0.03% 500
2023
Q3
$1.27M Hold
14,310
0.03% 485
2023
Q2
$1.24M Hold
14,310
0.03% 530
2023
Q1
$1.39M Hold
14,310
0.03% 449
2022
Q4
$1.48M Hold
14,310
0.04% 386
2022
Q3
$1.21M Buy
14,310
+522
+4% +$46.5K 0.1% 159
2022
Q2
$1.14M Hold
13,788
0.04% 461
2022
Q1
$1.06M Hold
13,788
0.03% 577
2021
Q4
$1.22M Hold
13,788
0.03% 543
2021
Q3
$1.06M Hold
13,788
0.03% 584
2021
Q2
$1.17M Hold
13,788
0.04% 449
2021
Q1
$1.04M Buy
13,788
+10,888
+375% +$889K 0.04% 469
2020
Q4
$241K Buy
+2,900
New +$230K 0.05% 417

Other funds holding BMRN

Maryland State Retirement & Pension System's BMRN Position: Q2 2026 in Review

Maryland State Retirement & Pension System held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 9,571 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #891.

Maryland State Retirement & Pension System first reported a position in BMRN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.48M in Q4 2022. 562 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Maryland State Retirement & Pension System held 9,571 shares of BioMarin Pharmaceuticals worth $548K as of Q2 2026.
  • Maryland State Retirement & Pension System left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #891 holding.
  • Maryland State Retirement & Pension System first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Maryland State Retirement & Pension System's BioMarin Pharmaceuticals position peaked at $1.48M in Q4 2022.
  • 562 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.